In ₹ Crore except Per Share Latest Annual	ELANTAS FY25	AMAL FY26	ARCL FY25	CHEMCRUX FY26	Peer Average
Valuation — at last close
P/E	70.19×	19.35×	◆ 14.56×	—	16.96× +314%
P/B	10.29×	◆ 0.88×	2.26×	—	1.57× +555%
EV/EBITDA	—	—	8.14×	—	8.14×
Market Cap	₹10,373 Cr	₹87.8 Cr	₹171 Cr	—	₹129 Cr +7913%
Growth
Revenue CAGR 3Y	—	◆ 29.43%	—	-4.61%	12.41%
Revenue CAGR 5Y	—	22.79%	—	—	22.79%
Net Income CAGR 3Y	—	◆ 83.96%	—	-68.48%	7.74%
Profitability
EBITDA Margin	◆ 20.31%	9.59%	9.48%	12.38%	10.48% +94%
Net Income Margin	◆ 17.43%	5.35%	4.69%	0.54%	3.53% +394%
Return on Common Equity	14.66%	4.64%	◆ 15.53%	—	10.08% +45%
Return on Capital Employed	14.45%	6.39%	◆ 18.49%	—	12.44% +16%
Return on Assets	◆ 12.67%	4.01%	7.30%	2.54%	4.62% +174%
Credit & Quality
Total Debt/Equity	—	—	0.46×	—	0.46×
Interest Coverage	◆ 293.96×	10.06×	3.81×	6.01×	6.63× +4336%
Scale — latest FY
Revenue / Total Income	₹848 Cr	₹84.9 Cr	₹251 Cr	₹82.6 Cr	₹139 Cr +508%
Net Income	₹148 Cr	₹4.5 Cr	₹11.8 Cr	₹0.4 Cr	₹5.6 Cr +2548%
Total Assets	₹1,166 Cr	₹117 Cr	₹161 Cr	₹17.7 Cr	₹98.5 Cr +1084%
EPS	₹186.41	₹28.9	₹14.69	—	₹21.79 +755%
Book Value per Share	₹1,271.75	₹633.73	₹94.57	—	₹364.15 +249%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.